✦ LIBER ✦

Negative Prostatic Biopsies in Patients with a High Risk of Prostate Cancer: Is the Combination of Endorectal MRI and Magnetic Resonance Spectroscopy Imaging (MRSI) a Useful Tool? A Preliminary Study

✍ Scribed by Delphine Amsellem-Ouazana; Patrick Younes; Sophie Conquy; Mickaël Peyromaure; Thierry Flam; Bernard Debré; Marc Zerbib

Book ID: 113608878
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 169 KB
Volume: 47
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2005.01.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

598Negative prostatic biopsies and high

598Negative prostatic biopsies and high risk patients. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study

✍ D. Amsellem-Ouazana; P. Younes; S. Conquynquy; M. Peyromaure; D. Saighi; T. Flam 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 184 KB

A pilot study of endorectal magnetic res

A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer

✍ Hans T. Chung; Susan M. Noworolski; John Kurhanewicz; Vivian Weinberg; Mack Roac 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

Role of magnetic resonance spectroscopic

Role of magnetic resonance spectroscopic imaging ([1H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA)

✍ V. Panebianco; A. Sciarra; M. Ciccariello; D. Lisi; S. Bernardo; S. Cattarino; V 📂 Article 📅 2010 🏛 Springer 🌐 Italian ⚖ 512 KB

Multiparametric magnetic resonance imagi

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

✍ Alessandro Sciarra; Valeria Panebianco; Susanna Cattarino; Gian Maria Busetto; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Impact of magnetic resonance imaging in

Impact of magnetic resonance imaging in the local staging, risk group classification and treatment of prostate cancer patients with combination of high dose rate brachytherapy and external beam radiotherapy

✍ Gomez-iturriaga, A.; Casquero, F.; Carvajal, C.; Urresola, A.; Canteli, B.; Ezqu 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 73 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB